Publications – Requests for Information Responses

  • Convention on Biological Diversity 2021 RFI

    Publication Date: June 2021

    EBRC’s response to the request from the Executive Secretariat to comment on the Convention on Biological Diversity Technical Series on Synthetic Biology to reflect advances in the rapidly growing field. As the regulatory landscape around synthetic biology emerges, it is crucial that these discussions are guided by science and expertise. In our submission, we provide detailed comments solicited and synthesized from our members— an international community of experts in synthetic biology from academia and industry.

  • NSF RFI on 2022-2026 Strategic Plan

    Publication Date: January 2021

    EBRC responds to the National Science Foundation’s Request for Information on its 2022-2026 Strategic Plan. EBRC addresses i) interests, values, and emerging science and policy issues; ii) US leadership in research and education; and iii) how the Strategic Plan can demonstrate the importance of fundamental research to the Nation.

  • National Defense Education Program 2021 RFI

    Publication Date: August 2020

    EBRC’s response to a Request for Information on behalf of the National Defense Education Program (NDEP) from the U.S. Department of Defense for the Office of the Under Secretary of Defense (Research & Engineering). This response: i) details the current status and limitations of the U.S. biotechnochnology education and workforce; ii) describes skillsets and capabilities needed for the future biotechnology workforce; iii) describes existing programs and models that can be leveraged or applied to support biotechnology education and workforce development, and the education levels where this would most impact; iv) recommends how to encourage the participation of minority and under-represented groups in biotechnology; and, v) describes metrics to measure progress and the level of investment necessary to ensure advancement.

  • HHS RFI on Review and Revision of the Screening Framework Guidance

    Publication Date: October 2020

    Many synthetic DNA synthesis companies screen their customers and the sequences they order in accordance with Guidance from the US Department of Health and Human Services. However, current guidance was issued in 2010 and thus is out of date. EBRC’s response to this RFI describes important considerations for updating the Guidance.

    • Back to top ⇑